Pfizer Inc. to Invest $200 Million in Irish Facility, Creating Jobs

Pharmaceutical company Pfizer is to invest €145m at its site in Clondalkin in Dublin. The company said it would expand its production and product testing facilities at the plant. It is thought up to 400 construction jobs will be created during peak construction periods. The site currently employs approximately 1,100 full time staff. It is one of the largest biotech manufacturing sites in the world and produces two of Pfizer's main drugs, Enbrel and Prevenar 13. The news has been welcomed by the Taoiseach and the IDA. Taoiseach Enda Kenny said the investment is a further demonstration of the company's continuous commitment to Ireland.